A structured clinical system for regenerative care
RMI Health is a physician-led regenerative medicine clinic in Costa Rica, delivering advanced therapies through structured medical protocols. Every program is guided by clinical evaluation, in-house laboratory control, and continuous physician oversight, prioritizing safety, scientific rigor, and measurable biological outcomes.
Our philosophy
Care guided by clinical reasoning.
At RMI, regenerative medicine is delivered through sequencing, not selection. We believe biological systems require preparation, immunomodulation, and controlled delivery in defined order. For this reason, our protocols often begin with therapeutic plasma exchange before cellular therapies are introduced.
Clinical appropriateness
Regenerative care is recommended only when medically suitable. Availability does not determine recommendation. Clinical judgment does.
Biological Compatibility
Therapies are introduced within a prepared physiological environment, aligned with structured sequencing and laboratory control.
Risk assessment
Risks, limitations, and contraindications are evaluated clearly before proceeding. Decisions are made with transparency.
Physician Discretion
Risks, limitations, and contraindications are evaluated clearly before proceeding. Decisions are made with transparency.
Medical Leadership
Renowned medical governance.
The Medical Leadership Team at RMI Health sets the institute’s clinical standards, leads protocol design, and safeguards the delivery of care through rigorous scientific validation, ethical governance, and an uncompromising commitment to long-term patient safety.
Dr. Vincent Giampapa, MD
Co-founder
A physician and pioneer in regenerative and anti-aging medicine, recognized for decades of work in cellular restoration science. A 2014 Nobel Prize nominee, he provides strategic medical leadership and guides RMI Health’s commitment to evidence-based regenerative care.
Dr. Victor Urzola, MD
Co-founder & CEO
A world-recognized plastic surgeon based in Costa Rica, with advanced training in plastic surgery from the University of Milan and microsurgery training in France. Since founding his practice in 2006, he has treated patients from over 28 countries, bringing global clinical expertise and multilingual care to RMI Health.
Dr. Jose Rojas, MD
Chief Medical Officer
A specialist in Internal Medicine and Pulmonology with over 24 years of clinical experience. Trained in medical research at Vanderbilt University and advanced bronchoscopy in Germany, he leads RMI Health as Chief Medical Officer, guiding clinical excellence, research, and international collaboration in regenerative and longevity medicine.
Executive LEADERSHIP
Leadership Committed to Long-Term Excellence
Dr. Valeria Tinoco, MD
Chief Operating Officer
Patrick Cunningham
Chief Commercial Officer
Leonardo Larios
Chief Financial Officer
clinical team
Physician responsibility at every stage
Natalia Jiménez, MSc
Lab Director
Dr. Andrés Soto, MD
Clinical Research Supervisor
Dr. Daniel Masís, MD
Head of Anesthesiology
Dr. Marcelo González, MD
Associate Physician - Muscularskeleton
Dr. Sebastian Waugh, MD
Associate Physician
Dr. Lucía Ruiz, MD
Associate Physician
Dr. Felipe Deliyore, MD
Division Lead - Muscularskeleton
Dr. Sergio Campos, MD
Associate Physician
In-House Laboratory
Standards-enforced regenerative medicine
RMI operates an ISO-5 and ISO-7 certified in-house laboratory where cellular preparation, handling, and verification occur under controlled environmental standards. Processing is not outsourced to third-party distributors, preserving consistency and physician alignment.
RMI operates an ISO 5 & ISO 7 certified in-house laboratory.
RMI Protocols
In-House Laboratory Processing
Cell preparation is conducted internally within ISO-5 & ISO-7 environmental controls. Maintaining in-house processing reduces transport-related variability and preserves environmental control over: Temperature, Handling time, Sterility conditions, Batch tracking
Quality Control & Batch Verification
Each cellular batch undergoes documented: Viability testing, Purity assessment, Documentation and labeling. Average live cell yield is approximately 80 percent, based on internal laboratory measurements.
Physician & Laboratory Oversight
Physicians and laboratory staff coordinate directly to align biological preparation with clinical timing. Preparation is synchronized with patient-specific treatment sequencing, not distributed through external intermediaries.
Standards-Driven Environment
The laboratory operates under ISO-7 certification and is currently pursuing GMP compliance to further formalize regulatory alignment. Processes are structured to prioritize consistency, traceability, and controlled handling at every stage.
NUMBERS THAT SUPPORT
Operational volume and oversight
RMI operates an ISO-5 & ISO-7 certified in-house laboratory where cellular preparation, handling, and verification occur under controlled environmental standards. Processing is not outsourced to third-party distributors, preserving consistency and physician alignment.
CELL VISIBILITY
Average live cell yield measured through internal batch-based viability testing under ISO-7 laboratory controls.
PATIENTS TREATED
Total patients evaluated and treated within RMI’s structured regenerative programs.
PROCEDURES PERFORMED (2025)
Treatment procedures delivered within the RMI clinical facility in 2025 alone.
RETURNING PATIENTS
Patients who returned for additional care, reflecting continuity within structured protocols.
FOLLOW-UP SCHEDULE
Structured post-treatment follow-up conducted at defined intervals up to six months.
CLINICAL EXPERIENCE
Combined physician experience in regenerative and cellular medicine.
RMI EXPERIENCE
Designed for clarity, pivacy and continuity
The RMI Experience: "Science, Costa Rica, and You" – Every stage of your journey combines advanced regenerative medicine with a destination experience, private coordination, thoughtful surroundings, and structured follow-up that make complex treatment feel clear, contained, and purposeful.
Explore
Eligibilty Review
A detailed consultation to understand your health history, clarify expectations, and define realistic, long‑term goals for treatment and recovery.
Medical Onboarding
You meet with an RMI physician to review your needs, confirm eligibility, and determine any testing required before treatment.
Treatment & Care
Within our state-of-the-art facility, regenerative therapies are delivered by experienced physicians in a quiet, closely supervised setting.
Privacy & Trust
Every interaction, consultation, and record is handled with care, ensuring that your data remains private and protected.
Concierge Experience
Everything around your stay is privately coordinated with the medical team, so your energy goes toward preparation, treatment, and recovery.
Ongoing Guidance
Scheduled check‑ins and virtual consultations keep your progress on track and your mind at ease, following your departure
Live longer with proven science
The longevity experience for those who demand more - designed to keep you sharp, mobile, and resilient.
Start Eligibility Review